|
GB939516A
(en)
|
1961-05-29 |
1963-10-16 |
British Drug Houses Ltd |
Sulphonyl ureas
|
|
US3702849A
(en)
|
1967-10-26 |
1972-11-14 |
Pfizer |
4-(isoquinolin-1-yl) piperazine-1-carboxylic acid esters
|
|
US3752660A
(en)
|
1971-03-15 |
1973-08-14 |
Allied Chem |
Chlorophenoxyacetyloxazolidone herbicides and preparation thereof
|
|
US4436748A
(en)
|
1980-10-20 |
1984-03-13 |
Hoechst-Roussel Pharmaceuticals Inc. |
Benzo[b]thiophenes
|
|
US4439606A
(en)
|
1982-05-06 |
1984-03-27 |
American Cyanamid Company |
Antiatherosclerotic 1-piperazinecarbonyl compounds
|
|
EP0094498A3
(en)
|
1982-05-06 |
1985-04-03 |
American Cyanamid Company |
Antiatherosclerotic 1-piperazine derivatives
|
|
US4656181A
(en)
|
1982-11-24 |
1987-04-07 |
Cermol S.A. |
Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
|
|
JPS59163372A
(ja)
|
1983-03-09 |
1984-09-14 |
Showa Denko Kk |
ピラゾ−ル誘導体とその製造法及び除草剤
|
|
JPS60193955A
(ja)
|
1984-03-13 |
1985-10-02 |
Mitsui Toatsu Chem Inc |
環式不飽和アミド置換エ−テル化合物及びその製造方法
|
|
JPS6143190A
(ja)
|
1984-08-06 |
1986-03-01 |
Mitsui Petrochem Ind Ltd |
ピリドピリミジン誘導体およびその製法
|
|
US4911920A
(en)
|
1986-07-30 |
1990-03-27 |
Alcon Laboratories, Inc. |
Sustained release, comfort formulation for glaucoma therapy
|
|
FR2588189B1
(fr)
|
1985-10-03 |
1988-12-02 |
Merck Sharp & Dohme |
Composition pharmaceutique de type a transition de phase liquide-gel
|
|
US5052558A
(en)
|
1987-12-23 |
1991-10-01 |
Entravision, Inc. |
Packaged pharmaceutical product
|
|
US5033252A
(en)
|
1987-12-23 |
1991-07-23 |
Entravision, Inc. |
Method of packaging and sterilizing a pharmaceutical product
|
|
US5010175A
(en)
|
1988-05-02 |
1991-04-23 |
The Regents Of The University Of California |
General method for producing and selecting peptides with specific properties
|
|
GB8827305D0
(en)
|
1988-11-23 |
1988-12-29 |
British Bio Technology |
Compounds
|
|
US5925525A
(en)
|
1989-06-07 |
1999-07-20 |
Affymetrix, Inc. |
Method of identifying nucleotide differences
|
|
IE66205B1
(en)
|
1990-06-14 |
1995-12-13 |
Paul A Bartlett |
Polypeptide analogs
|
|
US5650489A
(en)
|
1990-07-02 |
1997-07-22 |
The Arizona Board Of Regents |
Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
|
|
JP2594486B2
(ja)
|
1991-01-15 |
1997-03-26 |
アルコン ラボラトリーズ インコーポレイテッド |
局所的眼薬組成物
|
|
US5212162A
(en)
|
1991-03-27 |
1993-05-18 |
Alcon Laboratories, Inc. |
Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
|
|
US6017696A
(en)
|
1993-11-01 |
2000-01-25 |
Nanogen, Inc. |
Methods for electronic stringency control for molecular biological analysis and diagnostics
|
|
US6051380A
(en)
|
1993-11-01 |
2000-04-18 |
Nanogen, Inc. |
Methods and procedures for molecular biological analysis and diagnostics
|
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
|
US5288514A
(en)
|
1992-09-14 |
1994-02-22 |
The Regents Of The University Of California |
Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
|
|
US5455258A
(en)
|
1993-01-06 |
1995-10-03 |
Ciba-Geigy Corporation |
Arylsulfonamido-substituted hydroxamic acids
|
|
US5605798A
(en)
|
1993-01-07 |
1997-02-25 |
Sequenom, Inc. |
DNA diagnostic based on mass spectrometry
|
|
US5858659A
(en)
|
1995-11-29 |
1999-01-12 |
Affymetrix, Inc. |
Polymorphism detection
|
|
US6045996A
(en)
|
1993-10-26 |
2000-04-04 |
Affymetrix, Inc. |
Hybridization assays on oligonucleotide arrays
|
|
US6068818A
(en)
|
1993-11-01 |
2000-05-30 |
Nanogen, Inc. |
Multicomponent devices for molecular biological analysis and diagnostics
|
|
US5538848A
(en)
|
1994-11-16 |
1996-07-23 |
Applied Biosystems Division, Perkin-Elmer Corp. |
Method for detecting nucleic acid amplification using self-quenching fluorescence probe
|
|
IL111730A
(en)
|
1993-11-29 |
1998-12-06 |
Fujisawa Pharmaceutical Co |
Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
|
|
WO1995021271A1
(en)
|
1994-02-07 |
1995-08-10 |
Molecular Tool, Inc. |
Ligase/polymerase-mediated genetic bit analysistm of single nucleotide polymorphisms and its use in genetic analysis
|
|
US5593853A
(en)
|
1994-02-09 |
1997-01-14 |
Martek Corporation |
Generation and screening of synthetic drug libraries
|
|
US5539083A
(en)
|
1994-02-23 |
1996-07-23 |
Isis Pharmaceuticals, Inc. |
Peptide nucleic acid combinatorial libraries and improved methods of synthesis
|
|
US6309853B1
(en)
|
1994-08-17 |
2001-10-30 |
The Rockfeller University |
Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
|
|
JP2002515008A
(ja)
|
1994-10-27 |
2002-05-21 |
メルク エンド カンパニー インコーポレーテッド |
ムスカリン・アンタゴニスト
|
|
US5863949A
(en)
|
1995-03-08 |
1999-01-26 |
Pfizer Inc |
Arylsulfonylamino hydroxamic acid derivatives
|
|
ES2153031T4
(es)
|
1995-04-20 |
2001-05-16 |
Pfizer |
Derivados del acido arilsulfonil hidroxamico como inhibidores de mmp y tnf.
|
|
FR2734816B1
(fr)
|
1995-05-31 |
1997-07-04 |
Adir |
Nouveaux aryl (alkyl) propylamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US5977322A
(en)
|
1995-06-14 |
1999-11-02 |
The Regents Of The University Of California |
High affinity human antibodies to tumor antigens
|
|
ATE225343T1
(de)
|
1995-12-20 |
2002-10-15 |
Hoffmann La Roche |
Matrix-metalloprotease inhibitoren
|
|
US6011029A
(en)
|
1996-02-26 |
2000-01-04 |
Bristol-Myers Squibb Company |
Inhibitors of farnesyl protein transferase
|
|
EP0818442A3
(en)
|
1996-07-12 |
1998-12-30 |
Pfizer Inc. |
Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor
|
|
KR20000067904A
(ko)
|
1996-07-18 |
2000-11-25 |
디. 제이. 우드, 스피겔 알렌 제이 |
매트릭스 메탈로프로테아제의 포스피네이트계 억제제
|
|
KR20000068248A
(ko)
|
1996-08-23 |
2000-11-25 |
디. 제이. 우드, 스피겔 알렌 제이 |
아릴설포닐아미노 하이드록삼산 유도체
|
|
US5777324A
(en)
|
1996-09-19 |
1998-07-07 |
Sequenom, Inc. |
Method and apparatus for maldi analysis
|
|
JP3338064B2
(ja)
|
1997-01-06 |
2002-10-28 |
ファイザー・インク |
環状スルホン誘導体
|
|
NZ336840A
(en)
|
1997-02-03 |
2001-01-26 |
Pfizer Prod Inc |
Arylsulfonylamino hydroxamic acid derivatives useful in the treatment of tumor necrosis factor and matrix metalloproteinase mediated diseases
|
|
GB9702194D0
(en)
|
1997-02-04 |
1997-03-26 |
Lilly Co Eli |
Sulphonide derivatives
|
|
JP2000507975A
(ja)
|
1997-02-07 |
2000-06-27 |
ファイザー・インク |
Ｎ−ヒドロキシ−β−スルホニルプロピオンアミド誘導体類及びそれらのマトリックスメタロプロテイナーゼ阻害薬としての使用
|
|
EP0960098A1
(en)
|
1997-02-11 |
1999-12-01 |
Pfizer Inc. |
Arylsulfonyl hydroxamic acid derivatives
|
|
US6291464B1
(en)
|
1997-02-17 |
2001-09-18 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminopiperazine derivatives
|
|
US6002008A
(en)
|
1997-04-03 |
1999-12-14 |
American Cyanamid Company |
Substituted 3-cyano quinolines
|
|
UA73073C2
(uk)
|
1997-04-03 |
2005-06-15 |
Уайт Холдінгз Корпорейшн |
Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція
|
|
US5919626A
(en)
|
1997-06-06 |
1999-07-06 |
Orchid Bio Computer, Inc. |
Attachment of unmodified nucleic acids to silanized solid phase surfaces
|
|
ZA985205B
(en)
|
1997-06-17 |
1998-12-15 |
Schering Corp |
Novel n-substituted urea inhibitors of arnesyl-protein transferase
|
|
CA2299355C
(en)
|
1997-08-08 |
2005-09-27 |
Pfizer Products Inc. |
Aryloxyarylsulfonylamino hydroxamic acid derivatives
|
|
GB9725782D0
(en)
|
1997-12-05 |
1998-02-04 |
Pfizer Ltd |
Therapeutic agents
|
|
DE19756236A1
(de)
|
1997-12-17 |
1999-07-01 |
Klinge Co Chem Pharm Fab |
Neue piperazinylsubstituierte Pyridylalkan-, alken- und -alkincarbonsäureamide
|
|
US6903118B1
(en)
|
1997-12-17 |
2005-06-07 |
Klinge Pharma Gmbh |
Piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
|
|
EP1042299A1
(en)
|
1997-12-22 |
2000-10-11 |
Du Pont Pharmaceuticals Company |
Nitrogen containing heteroaromatics with ortho-substituted p1's as factor xa inhibitors
|
|
GB9801690D0
(en)
|
1998-01-27 |
1998-03-25 |
Pfizer Ltd |
Therapeutic agents
|
|
PA8469401A1
(es)
|
1998-04-10 |
2000-05-24 |
Pfizer Prod Inc |
Derivados biciclicos del acido hidroxamico
|
|
PA8469501A1
(es)
|
1998-04-10 |
2000-09-29 |
Pfizer Prod Inc |
Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico
|
|
EP1090293B2
(en)
|
1998-06-24 |
2019-01-23 |
Illumina, Inc. |
Decoding of array sensors with microspheres
|
|
EP1004578B1
(en)
|
1998-11-05 |
2004-02-25 |
Pfizer Products Inc. |
5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
|
|
US6429027B1
(en)
|
1998-12-28 |
2002-08-06 |
Illumina, Inc. |
Composite arrays utilizing microspheres
|
|
US6586447B1
(en)
|
1999-04-01 |
2003-07-01 |
Pfizer Inc |
3,3-disubstituted-oxindole derivatives useful as anticancer agents
|
|
US6511993B1
(en)
|
1999-06-03 |
2003-01-28 |
Kevin Neil Dack |
Metalloprotease inhibitors
|
|
GB9912961D0
(en)
|
1999-06-03 |
1999-08-04 |
Pfizer Ltd |
Metalloprotease inhibitors
|
|
EP1081137A1
(en)
|
1999-08-12 |
2001-03-07 |
Pfizer Products Inc. |
Selective inhibitors of aggrecanase in osteoarthritis treatment
|
|
DK1218542T3
(da)
|
1999-09-13 |
2004-08-02 |
Nugen Technologies Inc |
Fremgangsmåder og sammensætninger til lineær isotermisk amplifikation af polynukleotidsekvenser
|
|
TWI271406B
(en)
|
1999-12-13 |
2007-01-21 |
Eisai Co Ltd |
Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same
|
|
US6849639B2
(en)
|
1999-12-14 |
2005-02-01 |
Amgen Inc. |
Integrin inhibitors and their methods of use
|
|
CN1190197C
(zh)
|
2000-03-13 |
2005-02-23 |
惠氏控股公司 |
氰基喹啉用于制备治疗或抑制结肠息肉药物中的用途
|
|
NZ520656A
(en)
|
2000-03-21 |
2004-05-28 |
Procter & Gamble |
Heterocyclic side chain containing metalloprotease inhibitors
|
|
AU5889701A
(en)
|
2000-06-05 |
2001-12-17 |
Dong A Pharm Co Ltd |
Novel oxazolidinone derivatives and a process for the preparation thereof
|
|
TWI227231B
(en)
|
2000-07-12 |
2005-02-01 |
Novartis Ag |
4-benzoyl-piperidine derivatives for treating conditions mediated by CCR-3
|
|
PT1315715E
(pt)
|
2000-08-18 |
2008-10-30 |
Millennium Pharm Inc |
Derivados de quianazolina utilizados como inibidores de quinase
|
|
US6890747B2
(en)
|
2000-10-23 |
2005-05-10 |
Warner-Lambert Company |
Phosphoinositide 3-kinases
|
|
US7429599B2
(en)
|
2000-12-06 |
2008-09-30 |
Signal Pharmaceuticals, Llc |
Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
|
|
US20020169300A1
(en)
|
2001-01-30 |
2002-11-14 |
Waterman Marian L. |
Method of detection and treatment of colon cancer by analysis of beta-catenin-sensitive isoforms of lymphoid enhancer factor-1
|
|
CA2443108A1
(en)
|
2001-04-03 |
2002-10-17 |
Merck & Co. Inc. |
N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
|
|
US7074801B1
(en)
|
2001-04-26 |
2006-07-11 |
Eisai Co., Ltd. |
Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof
|
|
JP2002371078A
(ja)
|
2001-06-12 |
2002-12-26 |
Sankyo Co Ltd |
キノリン誘導体及びキノロン誘導体
|
|
ATE449090T1
(de)
|
2001-07-02 |
2009-12-15 |
High Point Pharmaceuticals Llc |
Substituierte piperazin- und diazepanderivate zur verwendung als histamin h3 rezeptormodulatoren
|
|
AU2002352444A1
(en)
|
2001-12-20 |
2003-07-09 |
Celltech R And D Limited |
Quinazolinedione derivatives
|
|
EP1348434A1
(en)
|
2002-03-27 |
2003-10-01 |
Fujisawa Deutschland GmbH |
Use of pyridyl amides as inhibitors of angiogenesis
|
|
WO2004033427A1
(en)
|
2002-10-11 |
2004-04-22 |
Astrazeneca Ab |
1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors
|
|
JP4608852B2
(ja)
|
2002-10-15 |
2011-01-12 |
チッソ株式会社 |
液晶性ビニルケトン誘導体およびその重合体
|
|
JP2004250329A
(ja)
|
2002-12-26 |
2004-09-09 |
Dainippon Pharmaceut Co Ltd |
イサチン誘導体
|
|
MXPA05008878A
(es)
|
2003-02-21 |
2005-10-05 |
Pfizer |
Derivados de aminotiazol sustituidos con cicloalquilo que contiene n y composiciones farmaceuticas para inhibir la proliferacion celular, y metodos para su uso.
|
|
PL1633724T3
(pl)
|
2003-03-12 |
2011-10-31 |
Kudos Pharm Ltd |
Pochodne ftalazynonu
|
|
US20050119266A1
(en)
|
2003-10-01 |
2005-06-02 |
Yan Shi |
Pyrrolidine and piperidine derivatives as factor Xa inhibitors
|
|
SE0302811D0
(sv)
|
2003-10-23 |
2003-10-23 |
Astrazeneca Ab |
Novel compounds
|
|
JP4923380B2
(ja)
|
2003-12-22 |
2012-04-25 |
Ｊｎｃ株式会社 |
低屈折率異方性化合物、組成物およびそれらの重合体または重合体組成物
|
|
GEP20084439B
(en)
|
2004-01-23 |
2008-07-25 |
Amgen Inc |
Nitrogen-containing heterocyclic derivatives and pharmaceutical use thereof
|
|
WO2005082892A2
(en)
|
2004-02-17 |
2005-09-09 |
Dr. Reddy's Laboratories Ltd. |
Triazole compounds as antibacterial agents and pharmaceutical compositions containing them
|
|
EP1723146A1
(en)
|
2004-03-01 |
2006-11-22 |
Eli Lilly And Company |
Fused pyrazole derivatives as tgf-beta signal transduction inhibitors for the treatment of fibrosis and neoplasms
|
|
GB0405628D0
(en)
|
2004-03-12 |
2004-04-21 |
Glaxo Group Ltd |
Novel compounds
|
|
JP4775259B2
(ja)
|
2004-03-31 |
2011-09-21 |
味の素株式会社 |
アニリン誘導体
|
|
GT200500375A
(es)
|
2004-12-20 |
2006-11-28 |
|
Derivados de piperidina y su uso como agentes antiinflamatorios
|
|
US20090264415A2
(en)
|
2004-12-30 |
2009-10-22 |
Steven De Jonghe |
Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment
|
|
GB0428475D0
(en)
|
2004-12-30 |
2005-02-02 |
4 Aza Bioscience Nv |
Pyrido(3,2-D)pyrimidine derivatives and pharmaceutical compositions useful as medicines for the treatment of autoimmune disorders
|
|
TW200643015A
(en)
|
2005-03-11 |
2006-12-16 |
Akzo Nobel Nv |
2-(4-oxo-4H-quinazolin-3-yl)acetamide derivatives
|
|
CA2599476A1
(en)
|
2005-03-16 |
2006-09-21 |
F. Hoffmann-La Roche Ag |
Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments
|
|
JP2007016011A
(ja)
|
2005-06-10 |
2007-01-25 |
Nippon Soda Co Ltd |
抗酸化活性を有する新規な含窒素ヘテロ環化合物、及び該化合物を含有する抗酸化薬
|
|
AU2006261607A1
(en)
|
2005-06-24 |
2006-12-28 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for treating hepatitis C.
|
|
WO2007047146A2
(en)
|
2005-10-11 |
2007-04-26 |
Intermune, Inc. |
Inhibitors of viral replication
|
|
TW200800201A
(en)
|
2005-11-18 |
2008-01-01 |
Lilly Co Eli |
Pyrimidinyl benzothiophene compounds
|
|
EP1966132A2
(en)
|
2005-12-15 |
2008-09-10 |
Boehringer Ingelheim International Gmbh |
Compounds which modulate the cb2 receptor
|
|
WO2007092435A2
(en)
|
2006-02-07 |
2007-08-16 |
Wyeth |
11-beta hsd1 inhibitors
|
|
PE20070978A1
(es)
|
2006-02-14 |
2007-11-15 |
Novartis Ag |
COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
|
|
MX2008012617A
(es)
|
2006-03-31 |
2008-10-10 |
Novartis Ag |
Compuestos organicos.
|
|
EP2059515A2
(en)
|
2006-04-12 |
2009-05-20 |
Pfizer Limited |
Pyrrolidine derivatives as modulators of chemokine ccr5 receptors
|
|
EP2038255A2
(en)
|
2006-06-16 |
2009-03-25 |
High Point Pharmaceuticals, LLC |
Pharmaceutical use of substituted piperidine carboxamides
|
|
US20080039450A1
(en)
|
2006-06-22 |
2008-02-14 |
Jensen Annika J |
Compounds
|
|
FR2903101B1
(fr)
|
2006-06-30 |
2008-09-26 |
Servier Lab |
Nouveaux derives naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
WO2008009078A2
(en)
|
2006-07-20 |
2008-01-24 |
Gilead Sciences, Inc. |
4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
|
|
AU2007275221A1
(en)
|
2006-07-20 |
2008-01-24 |
Allen J. Borchardt |
Benzothiophene inhibitors of RHO kinase
|
|
EP1903038A1
(de)
|
2006-09-07 |
2008-03-26 |
Bayer Schering Pharma Aktiengesellschaft |
N-(1-Hetaryl-piperidin-4-yl)-(het)arylamide als EP2-Rezeptor Modulatoren
|
|
MX2009002920A
(es)
|
2006-09-15 |
2009-04-01 |
Schering Corp |
Tratamiento del dolor, diabetes y trastornos del metabolismo de los lipidos.
|
|
JP2010520876A
(ja)
|
2007-03-09 |
2010-06-17 |
アストラゼネカ・アクチエボラーグ |
ピペラジンおよびピペリジンｍＧｌｕＲ５増強剤
|
|
MY162157A
(en)
|
2007-04-16 |
2017-05-31 |
Abbott Lab |
Substituted indole mcl-1 inhibitors
|
|
EP4230747A3
(en)
|
2008-03-28 |
2023-11-15 |
Pacific Biosciences Of California, Inc. |
Compositions and methods for nucleic acid sequencing
|
|
EP2133334A1
(en)
|
2008-06-09 |
2009-12-16 |
DAC S.r.l. |
Heterocyclic derivatives as HDAC inhibitors
|
|
JP5555236B2
(ja)
|
2008-08-25 |
2014-07-23 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
ヘッジホッグ経路モジュレーター
|
|
CA2743134A1
(en)
|
2008-11-10 |
2010-05-14 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
WO2010087399A1
(ja)
|
2009-01-30 |
2010-08-05 |
第一三共株式会社 |
ウロテンシンｉｉ受容体拮抗薬
|
|
JP2012524800A
(ja)
|
2009-04-22 |
2012-10-18 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
モノアシルグリセロールリパーゼ阻害剤としてのアゼチジニルジアミド
|
|
US20120083476A1
(en)
|
2009-06-05 |
2012-04-05 |
Janssen Pharmaceutica Nv |
Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase
|
|
EP2270002A1
(en)
|
2009-06-18 |
2011-01-05 |
Vereniging voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek en Patiëntenzorg |
Quinazoline derivatives as histamine H4-receptor inhibitors for use in the treatment of inflammatory disorders
|
|
ES2618630T3
(es)
|
2009-06-29 |
2017-06-21 |
Agios Pharmaceuticals, Inc. |
Composiciones terapéuticas y métodos de uso relacionados
|
|
WO2011016559A1
(ja)
|
2009-08-07 |
2011-02-10 |
武田薬品工業株式会社 |
複素環化合物およびその用途
|
|
KR101256018B1
(ko)
|
2009-08-20 |
2013-04-18 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 갖는 1,3,6-치환된 인돌 화합물
|
|
JP2013504325A
(ja)
|
2009-09-09 |
2013-02-07 |
アビラ セラピューティクス， インコーポレイテッド |
Ｐｉ３キナーゼインヒビターおよびその使用
|
|
KR101758046B1
(ko)
|
2009-12-22 |
2017-07-14 |
버텍스 파마슈티칼스 인코포레이티드 |
포스파티딜이노시톨 3-키나제의 이소인돌리논 억제제
|
|
JP2013516422A
(ja)
|
2009-12-30 |
2013-05-13 |
アビラ セラピューティクス， インコーポレイテッド |
タンパク質のリガンド−指向性共有的修飾
|
|
HRP20141190T1
(hr)
|
2010-01-29 |
2015-01-30 |
Otsuka Pharmaceutical Co., Ltd. |
Disupstituirani derivati piridina kao antikancerogena sredstva
|
|
CA2783665A1
(en)
|
2010-03-03 |
2011-09-09 |
OSI Pharmaceuticals, LLC |
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
|
|
GB201004200D0
(en)
|
2010-03-15 |
2010-04-28 |
Univ Basel |
Spirocyclic compounds and their use as therapeutic agents and diagnostic probes
|
|
BR112012022868A2
(pt)
|
2010-03-16 |
2018-06-05 |
Merck Patent Gmbh |
morfolinilquinazolinas
|
|
KR20130065632A
(ko)
|
2010-04-28 |
2013-06-19 |
다이이찌 산쿄 가부시키가이샤 |
［５，６］복소 고리 화합물
|
|
TW201202230A
(en)
|
2010-05-24 |
2012-01-16 |
Mitsubishi Tanabe Pharma Corp |
Novel quinazoline compound
|
|
WO2011153553A2
(en)
|
2010-06-04 |
2011-12-08 |
The Regents Of The University Of California |
Methods and compositions for kinase inhibition
|
|
EP2580378A4
(en)
|
2010-06-08 |
2014-01-01 |
Nugen Technologies Inc |
MULTIPLEX SEQUENCING METHODS AND COMPOSITION
|
|
US8658131B2
(en)
|
2010-06-21 |
2014-02-25 |
Washington University |
Compounds comprising 4-benzoylpiperidine as a sigma-1-selective ligand
|
|
CA2806332C
(en)
|
2010-07-30 |
2017-11-14 |
Oncotherapy Science, Inc. |
Quinoline derivatives and melk inhibitors containing the same
|
|
CN103068798A
(zh)
|
2010-09-03 |
2013-04-24 |
詹森药业有限公司 |
作为单酰甘油脂肪酶抑制剂的二-氮杂环丁烷二酰胺
|
|
US8883791B2
(en)
|
2010-09-29 |
2014-11-11 |
Intervet Inc. |
N-heteroaryl compounds with cyclic bridging unit for the treatment of parasitic diseases
|
|
JP2013540159A
(ja)
|
2010-10-22 |
2013-10-31 |
ヤンセン ファーマシューティカ エヌ．ベー． |
モノアシルグリセロールリパーゼ阻害剤としてのピペリジン−４−イル−アゼチジンジアミド
|
|
US20130225524A1
(en)
|
2010-11-05 |
2013-08-29 |
Deping Chai |
Chemical Compounds
|
|
WO2012174489A2
(en)
|
2011-06-15 |
2012-12-20 |
The Ohio State University |
Small molecule composite surfaces as inhibitors of protein-protein interactions
|
|
CA2840627A1
(en)
|
2011-06-29 |
2013-01-03 |
Otsuka Pharmaceutical Co., Ltd. |
Quinazolines as therapeutic compounds and related methods of use
|
|
CN103087077B
(zh)
|
2011-11-03 |
2016-05-18 |
上海希迈医药科技有限公司 |
噻吩并嘧啶和呋喃并嘧啶类衍生物、其制备方法及其在医药上的应用
|
|
JP2013107855A
(ja)
|
2011-11-22 |
2013-06-06 |
Mitsubishi Tanabe Pharma Corp |
医薬組成物
|
|
US9745631B2
(en)
|
2011-12-20 |
2017-08-29 |
Dana-Farber Cancer Institute, Inc. |
Methods for diagnosing and treating oncogenic kras-associated cancer
|
|
WO2013096151A1
(en)
|
2011-12-22 |
2013-06-27 |
Glaxosmithkline Llc |
Chemical compounds
|
|
ES2575604T3
(es)
|
2012-01-13 |
2016-06-29 |
Bristol-Myers Squibb Company |
Compuestos de piridilo sustituidos con tiazolilo o tiadiazolilo útiles como inhibidores cinasa
|
|
AU2013237226A1
(en)
|
2012-03-19 |
2014-10-09 |
Emory University |
Quinazoline compounds and their use in therapy
|
|
WO2013155077A1
(en)
|
2012-04-09 |
2013-10-17 |
Board Of Regents,The University Of Texas System |
Response markers for src inhibitor therapies
|
|
EP2836482B1
(en)
|
2012-04-10 |
2019-12-25 |
The Regents of The University of California |
Compositions and methods for treating cancer
|
|
ES3039913T3
(en)
|
2012-05-09 |
2025-10-27 |
Gradalis Inc |
Bi-functional short-hairpin rna (bi-shrna) specific for single-nucleotide kras mutations
|
|
JO3300B1
(ar)
|
2012-06-06 |
2018-09-16 |
Novartis Ag |
مركبات وتركيبات لتعديل نشاط egfr
|
|
SG11201500125QA
(en)
|
2012-07-11 |
2015-02-27 |
Blueprint Medicines Corp |
Inhibitors of the fibroblast growth factor receptor
|
|
TW201414737A
(zh)
|
2012-07-13 |
2014-04-16 |
必治妥美雅史谷比公司 |
作爲激酶抑制劑之咪唑并三□甲腈
|
|
JPWO2014030743A1
(ja)
|
2012-08-24 |
2016-08-08 |
武田薬品工業株式会社 |
複素環化合物
|
|
US20150283142A1
(en)
|
2013-03-15 |
2015-10-08 |
Infinity Pharmaceuticals, Inc. |
Treatment of cancers using pi3 kinase isoform modulators
|
|
WO2014081718A1
(en)
|
2012-11-20 |
2014-05-30 |
Genentech, Inc. |
Aminopyrimidine compounds as inhibitors of t790m containing egfr mutants
|
|
EA201591746A1
(ru)
|
2013-03-14 |
2016-08-31 |
КОНВЕРДЖЕН ЭлЭлСи |
Способы и композиции для ингибирования бромодомен-содержащих белков
|
|
US9227978B2
(en)
|
2013-03-15 |
2016-01-05 |
Araxes Pharma Llc |
Covalent inhibitors of Kras G12C
|
|
CA2903813C
(en)
|
2013-03-15 |
2023-08-29 |
Epizyme, Inc. |
Carm1 inhibitors and uses thereof
|
|
US9745319B2
(en)
|
2013-03-15 |
2017-08-29 |
Araxes Pharma Llc |
Irreversible covalent inhibitors of the GTPase K-Ras G12C
|
|
JP6518656B2
(ja)
|
2013-06-13 |
2019-05-22 |
バイオデシー， インコーポレイテッド |
標的生体実体を標的にする生化学実体候補をスクリーニングする方法
|
|
WO2014210255A1
(en)
|
2013-06-26 |
2014-12-31 |
Abbvie Inc. |
Primary carboxamides as btk inhibitors
|
|
US20150005277A1
(en)
|
2013-06-28 |
2015-01-01 |
Beigene, Ltd. |
Protein Kinase Inhibitors and Uses Thereof
|
|
DK3016946T3
(da)
|
2013-07-03 |
2023-01-09 |
Karyopharm Therapeutics Inc |
Substituerede benzofuranyl- og benzoxazolylforbindelser og anvendelser deraf
|
|
RS58361B1
(sr)
|
2013-07-31 |
2019-03-29 |
Merck Patent Gmbh |
Piridini, pirimidini i pirazini, kao inhibitori btk i njihova upotreba
|
|
CN104418860B
(zh)
|
2013-08-20 |
2016-09-07 |
中国科学院广州生物医药与健康研究院 |
嘧啶并杂环类化合物及其药用组合物和应用
|
|
BR112016005199B1
(pt)
|
2013-08-23 |
2022-02-22 |
Neupharma, Inc |
Certos compostos químicos, composições, e métodos
|
|
JO3805B1
(ar)
|
2013-10-10 |
2021-01-31 |
Araxes Pharma Llc |
مثبطات كراس جي12سي
|
|
US9376559B2
(en)
|
2013-11-22 |
2016-06-28 |
Exxonmobil Chemical Patents Inc. |
Reverse staged impact copolymers
|
|
US9695165B2
(en)
|
2014-01-15 |
2017-07-04 |
Blueprint Medicines Corporation |
Inhibitors of the fibroblast growth factor receptor
|
|
WO2015132799A2
(en)
|
2014-02-03 |
2015-09-11 |
Cadila Healthcare Limited |
Novel heterocyclic compounds
|
|
CA2943220C
(en)
|
2014-03-20 |
2024-01-16 |
Capella Therapeutics, Inc. |
Benzimidazole derivatives as erbb tyrosine kinase inhibitors for the treatment of cancer
|
|
SG11201607973XA
(en)
|
2014-03-24 |
2016-11-29 |
Guangdong Zhongsheng Pharmaceutical Co Ltd |
Quinoline derivatives as smo inhibitors
|
|
MA40074A
(fr)
|
2014-05-30 |
2015-12-03 |
Univ Columbia |
Composés liant ras multivalents
|
|
EP3827836A1
(en)
|
2014-06-27 |
2021-06-02 |
Celgene Corporation |
Compositions and methods for inducing conformational changes in cereblon and other e3 ubiquitin ligases
|
|
WO2016044604A1
(en)
|
2014-09-17 |
2016-03-24 |
Epizyme, Inc. |
Carm1 inhibitors and uses thereof
|
|
JO3556B1
(ar)
|
2014-09-18 |
2020-07-05 |
Araxes Pharma Llc |
علاجات مدمجة لمعالجة السرطان
|
|
WO2016049568A1
(en)
|
2014-09-25 |
2016-03-31 |
Araxes Pharma Llc |
Methods and compositions for inhibition of ras
|
|
WO2016049565A1
(en)
|
2014-09-25 |
2016-03-31 |
Araxes Pharma Llc |
Compositions and methods for inhibition of ras
|
|
JP2017528498A
(ja)
|
2014-09-25 |
2017-09-28 |
アラクセス ファーマ エルエルシー |
Ｋｒａｓ ｇ１２ｃ変異体タンパク質のインヒビター
|
|
EP3204383B1
(en)
|
2014-10-08 |
2020-11-18 |
F.Hoffmann-La Roche Ag |
Spirodiamine derivatives as aldosterone synthase inhibitors
|
|
CN105837576B
(zh)
|
2015-01-14 |
2019-03-26 |
湖北生物医药产业技术研究院有限公司 |
Btk抑制剂
|
|
EP3247353A4
(en)
|
2015-01-23 |
2018-07-04 |
Confluence Life Sciences, Inc. |
Heterocyclic itk inhibitors for treating inflammation and cancer
|
|
EP3270694A4
(en)
|
2015-02-17 |
2018-09-05 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
|
EP3277678B1
(en)
|
2015-04-03 |
2020-03-18 |
NantBio, Inc. |
Compositions and methods of targeting mutant k-ras
|
|
US10428064B2
(en)
|
2015-04-15 |
2019-10-01 |
Araxes Pharma Llc |
Fused-tricyclic inhibitors of KRAS and methods of use thereof
|
|
EP3288943B1
(en)
|
2015-05-01 |
2022-09-28 |
Pfizer Inc. |
Pyrrolo[2,3-b]pyrazinyl acrylamides and epoxides thereof as inhibitors of janus kinase
|
|
US10144724B2
(en)
|
2015-07-22 |
2018-12-04 |
Araxes Pharma Llc |
Substituted quinazoline compounds and methods of use thereof
|
|
WO2017058805A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
|
WO2017058728A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
|
EP3356349A1
(en)
|
2015-09-28 |
2018-08-08 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
|
EP3356359B1
(en)
|
2015-09-28 |
2021-10-20 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
|
EP3356347A1
(en)
|
2015-09-28 |
2018-08-08 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
|
WO2017058902A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
|
EP3356351A1
(en)
|
2015-09-28 |
2018-08-08 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
|
WO2017070256A2
(en)
|
2015-10-19 |
2017-04-27 |
Araxes Pharma Llc |
Method for screening inhibitors of ras
|
|
HUE068392T2
(hu)
|
2015-10-21 |
2024-12-28 |
Otsuka Pharma Co Ltd |
Benzolaktám vegyületek mint fehérje kináz gátlók
|
|
KR20180081596A
(ko)
*
|
2015-11-16 |
2018-07-16 |
아락세스 파마 엘엘씨 |
치환된 헤테로사이클릭 그룹을 포함하는 2-치환된 퀴나졸린 화합물 및 이의 사용 방법
|
|
US9988357B2
(en)
|
2015-12-09 |
2018-06-05 |
Araxes Pharma Llc |
Methods for preparation of quinazoline derivatives
|
|
CN105348271A
(zh)
|
2015-12-23 |
2016-02-24 |
常州润诺生物科技有限公司 |
喹唑啉类衍生物药用用途及其制备方法
|
|
CN105399734A
(zh)
|
2015-12-23 |
2016-03-16 |
吉林省长源药业有限公司 |
新型egfr抑制剂及其制备方法
|
|
WO2017172979A1
(en)
|
2016-03-30 |
2017-10-05 |
Araxes Pharma Llc |
Substituted quinazoline compounds and methods of use
|
|
CN105924840A
(zh)
|
2016-06-01 |
2016-09-07 |
扬州兰都塑料科技有限公司 |
一种阻燃电力电缆
|
|
CN106084164A
(zh)
|
2016-06-12 |
2016-11-09 |
四川大学 |
一种结构抗菌型聚氨酯用扩链剂的制备方法
|
|
US10646488B2
(en)
|
2016-07-13 |
2020-05-12 |
Araxes Pharma Llc |
Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof
|
|
WO2018064510A1
(en)
|
2016-09-29 |
2018-04-05 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
|
EP3523289A1
(en)
|
2016-10-07 |
2019-08-14 |
Araxes Pharma LLC |
Heterocyclic compounds as inhibitors of ras and methods of use thereof
|
|
IL266181B2
(en)
|
2016-11-03 |
2024-04-01 |
Corvus Pharmaceuticals Inc |
Compounds and methods for modulating interleukin-2-inducible t-cell kinase
|
|
WO2018140599A1
(en)
|
2017-01-26 |
2018-08-02 |
Araxes Pharma Llc |
Benzothiophene and benzothiazole compounds and methods of use thereof
|
|
WO2018140513A1
(en)
|
2017-01-26 |
2018-08-02 |
Araxes Pharma Llc |
1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1yl)prop-2-en-1-one derivatives and similar compounds as kras g12c modulators for treating cancer
|
|
EP3573966A1
(en)
|
2017-01-26 |
2019-12-04 |
Araxes Pharma LLC |
Fused n-heterocyclic compounds and methods of use thereof
|
|
US11136308B2
(en)
|
2017-01-26 |
2021-10-05 |
Araxes Pharma Llc |
Substituted quinazoline and quinazolinone compounds and methods of use thereof
|
|
EP3573954A1
(en)
|
2017-01-26 |
2019-12-04 |
Araxes Pharma LLC |
Fused bicyclic benzoheteroaromatic compounds and methods of use thereof
|
|
JP7327802B2
(ja)
|
2017-01-26 |
2023-08-16 |
アラクセス ファーマ エルエルシー |
縮合ヘテロ－ヘテロ二環式化合物およびその使用方法
|
|
JOP20190186A1
(ar)
|
2017-02-02 |
2019-08-01 |
Astellas Pharma Inc |
مركب كينازولين
|
|
US10745385B2
(en)
|
2017-05-25 |
2020-08-18 |
Araxes Pharma Llc |
Covalent inhibitors of KRAS
|
|
CN110869357A
(zh)
|
2017-05-25 |
2020-03-06 |
亚瑞克西斯制药公司 |
化合物及其用于治疗癌症的使用方法
|
|
WO2018218069A1
(en)
|
2017-05-25 |
2018-11-29 |
Araxes Pharma Llc |
Quinazoline derivatives as modulators of mutant kras, hras or nras
|
|
CA3098574A1
(en)
|
2018-05-04 |
2019-11-07 |
Amgen Inc. |
Kras g12c inhibitors and methods of using the same
|
|
MX2021000887A
(es)
|
2018-08-01 |
2021-03-31 |
Araxes Pharma Llc |
Compuestos espiroheterociclicos y metodos de uso de los mismos para el tratamiento de cancer.
|
|
CN113207291A
(zh)
|
2018-10-24 |
2021-08-03 |
亚瑞克西斯制药公司 |
2-(2-丙烯酰基-2,6-二氮杂螺[3.4]辛-6-基)-6-(1h-吲唑-4-基)苄腈衍生物及相关化合物作为用于抑制肿瘤转移的g12c突变kras蛋白的抑制剂
|
|
EP3887373A1
(en)
|
2018-11-29 |
2021-10-06 |
Araxes Pharma LLC |
Compounds and methods of use thereof for treatment of cancer
|